Key result
A single 200-joule synchronized direct current cardioversion successfully restored sinus rhythm in a 22-week pregnant patient with acute atrial fibrillation, without adverse maternal or fetal events.
Why the study?
Atrial fibrillation is uncommon in pregnancy but associated with significant mortality, and controlled studies evaluating therapeutic management are lacking.
Does direct current cardioversion safely restore sinus rhythm in a pregnant patient with acute symptomatic atrial fibrillation?
Case Report (n=1)
Does direct current cardioversion safely restore sinus rhythm in a pregnant patient with acute symptomatic atrial fibrillation?
This case report demonstrates that direct current cardioversion can be safely and effectively performed in a pregnant patient with acute symptomatic atrial fibrillation in a non-obstetric emergency department.
Supports DCCV for symptomatic AF in mid-pregnancy; leaves open need for controlled trials before changing practice.
Atrial Fibrillation (AF) is uncommon in pregnancy but associated with significant mortality. Although controlled studies evaluating therapeutic management of AF in pregnancy are lacking, current guidelines suggest that direct current cardioversion (DCCV) is safe in cases of maternal arrhythmia with hemodynamic compromise. In this report, we discuss a female patient of 22 weeks gestation who presented to the non-obstetric Emergency Department (ED) with acute onset, symptomatic AF. Following consultation with emergency medicine, cardiology, and maternal-fetal medicine specialists, rhythm control was favored for immediate management. A single 200 joules synchronized shock resulted in a successful reversion to sinus rhythm with no adverse events using agreed procedural sedation protocols. The patient had an uneventful inpatient course and was later discharged with outpatient cardiology and obstetric follow-up. This case contributes to the evidence that DCCV is safe in pregnant patients and proposes that standard medications used for analgesia and sedation in cardioversion are safe in pregnancy. A multidisciplinary team approach is key in managing AF in pregnancy in the acute non-obstetric setting.
No takes yet. Share an insight, caveat, or question.
Hilmi et al. (2024) conducted a case report in Atrial Fibrillation in pregnancy (n=1). Direct current cardioversion (DCCV) was evaluated on Reversion to sinus rhythm. A single 200-joule synchronized direct current cardioversion successfully restored sinus rhythm in a 22-week pregnant patient with acute atrial fibrillation, without adverse maternal or fetal events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: